DOUBLE-EXPRESSOR LYMPHOMA

Clinical trials for DOUBLE-EXPRESSOR LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new DOUBLE-EXPRESSOR LYMPHOMA trials appear

Sign up with your email to follow new studies for DOUBLE-EXPRESSOR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2

New hope for aggressive lymphoma: targeted combo trial launches

Disease control Not yet recruiting

This study tests whether a new combination of drugs (C Pola R-CHP+X) works better than the current standard treatment for people with a fast-growing type of lymphoma called double-expressor DLBCL. About 156 adults aged 18 to 75 who have not been treated before will take part. The…

Matched conditions: DOUBLE-EXPRESSOR LYMPHOMA

Phase: PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control

Last updated May 17, 2026 06:59 UTC

DOUBLE-EXPRESSOR LYMPHOMA

Get alerted when new DOUBLE-EXPRESSOR LYMPHOMA trials appear

New hope for aggressive lymphoma: targeted combo trial launches